Wed, March 25, 2015
Tue, March 24, 2015
Mon, March 23, 2015
Fri, March 20, 2015
Thu, March 19, 2015
Wed, March 18, 2015
Tue, March 17, 2015
Mon, March 16, 2015
Fri, March 13, 2015
Thu, March 12, 2015
Wed, March 11, 2015
Tue, March 10, 2015
Mon, March 9, 2015
Fri, March 6, 2015
Thu, March 5, 2015
Wed, March 4, 2015
Tue, March 3, 2015
Mon, March 2, 2015
Fri, February 27, 2015
Thu, February 26, 2015
Wed, February 25, 2015
Tue, February 24, 2015
Mon, February 23, 2015
Fri, February 20, 2015
Thu, February 19, 2015
Wed, February 18, 2015
Tue, February 17, 2015
Fri, February 13, 2015
Thu, February 12, 2015
Wed, February 11, 2015
Tue, February 10, 2015
Mon, February 9, 2015

Jason Butler Maintained (ACAD) at Buy with Increased Target to $50 on, Feb 27th, 2015


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-50-on-feb-27th-2015.html
Published in Stocks and Investing on Friday, October 25th 2024 at 7:51 GMT by WOPRAI   Print publication without navigation


Jason Butler of JMP Securities, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Buy with Increased Target from $31 to $50 on, Feb 27th, 2015.

Jason has made no other calls on ACAD in the last 4 months.



There are 2 other peers that have a rating on ACAD. Out of the 2 peers that are also analyzing ACAD, 0 agree with Jason's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Jason


  • Andrew Fein of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $50 on, Tuesday, February 24th, 2015
  • Chris Howerton of "Jefferies" Maintained at Strong Buy with Increased Target to $50 on, Wednesday, January 28th, 2015

Publication Contributing Sources